130 related articles for article (PubMed ID: 15154100)
1. American Chemical Society--227th annual meeting. Diabetes. 28 March - 1 April 2004, Anaheim, CA, USA.
Rotella DP
IDrugs; 2004 May; 7(5):428-9. PubMed ID: 15154100
[No Abstract] [Full Text] [Related]
2. American Chemical Society--227th annual meeting. Highlights. 28 March - 1 April 2004, Anaheim, CA, USA.
Garvey R; Veryard C
IDrugs; 2004 May; 7(5):426-7. PubMed ID: 15154099
[No Abstract] [Full Text] [Related]
3. Insulin glulisine: viewpoints.
Dailey G; Ahmadian M; Duckworth WC; Eckel J
Drugs; 2006; 66(6):870-2. PubMed ID: 16706559
[No Abstract] [Full Text] [Related]
4. American Chemical Society--227th Annual Meeting. Antibacterials and anti-inflammatories. 28 March - 1 April 2004, Anaheim, CA, USA.
Garvey R; Veryard C
IDrugs; 2004 May; 7(5):420-2. PubMed ID: 15154097
[No Abstract] [Full Text] [Related]
5. American Chemical Society--227th Annual Meeting. NMDA receptor. 28 March - 1 April 2004, Anaheim, CA, USA.
Rotella DP
IDrugs; 2004 May; 7(5):433-5. PubMed ID: 15154102
[No Abstract] [Full Text] [Related]
6. American Chemical Society--227th annual meeting. Neuroprotection. 28 March - 1 April 2004, Anaheim, CA, USA.
Rotella DP
IDrugs; 2004 May; 7(5):430-2. PubMed ID: 15154101
[No Abstract] [Full Text] [Related]
7. American Chemical Society--227th Annual Meeting. New disclosures. 28 March - 1 April 2004, Anaheim, CA, USA.
Garvey R; Veryard C
IDrugs; 2004 May; 7(5):423-5. PubMed ID: 15154098
[No Abstract] [Full Text] [Related]
8. Insulin lispro.
Holleman F; Hoekstra JB
N Engl J Med; 1997 Jul; 337(3):176-83. PubMed ID: 9219705
[No Abstract] [Full Text] [Related]
9. [Better blood sugar control in diabetics. Insulin glargin--a long-acting insulin analogue].
Schubert-Zsilavecz M; Wurglics M
Pharm Unserer Zeit; 2001; 30(2):125-30. PubMed ID: 11279982
[No Abstract] [Full Text] [Related]
10. Benefits of lispro insulin: control of postprandial glucose levels is within reach.
Bohannon NJ
Postgrad Med; 1997 Feb; 101(2):73-6, 79-80. PubMed ID: 9046927
[TBL] [Abstract][Full Text] [Related]
11. [Patients with diabetes mellitus. Medications which can regulate the blood sugar level].
van der Kuy A
Tijdschr Ziekenverpl; 1979 Oct; 32(21):967-9. PubMed ID: 259373
[No Abstract] [Full Text] [Related]
12. [Insulin analogs].
Pfützner A
Med Klin (Munich); 1996 Feb; 91 Suppl 1():17-8. PubMed ID: 8839107
[No Abstract] [Full Text] [Related]
13. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
[No Abstract] [Full Text] [Related]
14. Insulin detemir: improving the predictability of glycaemic control.
Russell-Jones D
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S29-34. PubMed ID: 15306835
[TBL] [Abstract][Full Text] [Related]
15. [Insulin glargine (HOE901)].
Iwamoto Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():503-10. PubMed ID: 12387042
[No Abstract] [Full Text] [Related]
16. [Flexibility and effectiveness of diabetes therapy].
Krankenpfl J; 2005; 43(1-3):62. PubMed ID: 15912849
[No Abstract] [Full Text] [Related]
17. [Insulin detemir (NN304)].
Kaku K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():511-5. PubMed ID: 12387043
[No Abstract] [Full Text] [Related]
18. Vanadium compounds as insulin mimics.
Orvig C; Thompson KH; Battell M; McNeill JH
Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
[TBL] [Abstract][Full Text] [Related]
19. Advances in insulin therapy: a review of insulin degludec.
King A
J Fam Pract; 2012 May; 61(5 Suppl):S28-31. PubMed ID: 22577639
[No Abstract] [Full Text] [Related]
20. Optimizing glycemic control with insulin glargine.
Williams JB
Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
